Daniel Christopher Brookings,Victoria Elizabeth Jackson
申请号：
US15101044
公开号：
US09850240B2
申请日:
2014.12.08
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A series of substituted [1,2,4]triazolo[4,3-a]pyridine derivatives, being potent modulators of human TNF activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders； neurological and neurodegenerative disorders； pain and nociceptive disorders； cardiovascular disorders； metabolic disorders； ocular disorders； and oncological disorders.
